Researchers at the University of Edinburgh have made a major breakthrough in the development of a treatment for Parkinson’s disease. Clinical trials are currently underway that utilize stem cells to treat Parkinson’s by injecting healthy stem cells directly into the brain. However, there is one major hurdle: the healthy injected cells can become diseased from the nearby cells exhibiting Parkinson’s symptoms. In lab tests, the researchers used CRISPR to splice the DNA of the stem cells to eradicate the gene that causes the toxic clumps of cells in the brain, which contribute to the neuronal degeneration. The edited stem cells also successfully produced dopamine, which is significantly lacking in Parkinson’s patients.
The research has the potential to increase the efficacy and prolong the effects of current stem cell based regenerative Parkinson’s disease treatments. Dr. Tilo Kunath, lead researcher of the study, comments "We know that Parkinson's disease spreads from neuron-neuron, invading healthy cells. This could essentially put a shelf life on the potential of cell replacement therapy. Our exciting discovery has the potential to considerably improve these emerging treatments."
The University of Edinburgh’s innovative research demonstrates the integral role stem cells are playing in cutting edge medical care options. By banking their own valuable stem cells, families can ensure that they will have access to these emerging therapies in the near future. To learn more about banking stem cells, please visit StemSave or call 877-783- 6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.